Nima Kokabi Selected Research

Yttrium-90

11/2023	Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma.
10/2023	Authors' Reply: Short- and Long-Term Outcomes for Resin-Based Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma Should Be Further Investigated.
1/2023	Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization.
1/2023	Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Comparative Study of the Effectiveness, Safety, and Dosimetry of Glass-Based versus Resin-Based Microspheres.
1/2023	Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry.
12/2022	Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial.
11/2022	Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90).
12/2021	Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma.
10/2021	Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.
8/2021	Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nima Kokabi Research Topics

Disease

32	Neoplasms (Cancer) 02/2024 - 07/2013
23	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 07/2013
11	Neoplasm Metastasis (Metastasis) 11/2022 - 08/2014
6	Cholangiocarcinoma 01/2023 - 02/2014
5	Liver Neoplasms (Liver Cancer) 02/2024 - 01/2016
5	Wounds and Injuries (Trauma) 12/2023 - 11/2014
5	Thrombosis (Thrombus) 12/2023 - 02/2014
4	Breast Neoplasms (Breast Cancer) 10/2023 - 06/2020
4	Pain (Aches) 03/2022 - 02/2020
3	Hemorrhage 01/2023 - 11/2019
3	Fibrosis (Cirrhosis) 01/2023 - 01/2020
3	Abdominal Pain (Pain, Abdominal) 01/2021 - 01/2017
3	Renal Cell Carcinoma (Grawitz Tumor) 07/2018 - 05/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2023 - 11/2022
2	Pulmonary Embolism 12/2023 - 11/2022
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2023 - 11/2022
2	Pathologic Constriction (Stenosis) 12/2023 - 01/2020
2	Postpartum Hemorrhage 01/2023 - 01/2022
2	Shock 06/2022 - 01/2022
2	Infections 05/2021 - 09/2019
2	Fatigue 01/2021 - 01/2017
2	Abdominal Abscess 01/2021 - 11/2019
2	Aspiration Pneumonia 01/2021 - 11/2019
2	Leiomyoma (Uterine Fibroids) 10/2020 - 02/2020
2	Ascites 06/2020 - 07/2015
2	Melanoma (Melanoma, Malignant) 02/2020 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 02/2016 - 08/2014
1	Hypoxia (Hypoxemia) 02/2024
1	Portal Hypertension 12/2023
1	Placenta Accreta 01/2023
1	Stroke (Strokes) 12/2022
1	Osteoarthritis 03/2022
1	Arthralgia (Joint Pain) 03/2022
1	Lacerations 01/2022
1	Placenta Previa 01/2022
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022
1	Rupture 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	COVID-19 05/2021
1	Knee Osteoarthritis 04/2021
1	Cellulitis 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Emphysematous Cholecystitis 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Short Bowel Syndrome 01/2020

Drug/Important Bio-Agent (IBA)

29	Yttrium-90IBA 11/2023 - 07/2013
6	AlbuminsIBA 12/2022 - 02/2014
5	Biomarkers (Surrogate Marker)IBA 08/2018 - 10/2014
3	Metformin (Glucophage)FDA LinkGeneric 09/2023 - 12/2021
2	SirtuinsIBA 09/2021 - 01/2017
2	Technetium-99IBA 01/2021 - 11/2019
2	BilirubinIBA 01/2021 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2015 - 10/2015
2	YttriumIBA 09/2015 - 07/2015
1	Proteins (Proteins, Gene)FDA Link 02/2024
1	Oxygen (Dioxygen)IBA 02/2024
1	NivolumabIBA 11/2023
1	Immune Checkpoint InhibitorsIBA 11/2023
1	Bevacizumab (Avastin)FDA Link 11/2023
1	atezolizumabIBA 11/2023
1	tyramine-deoxysorbitolIBA 01/2023
1	hydroxide ionIBA 08/2021
1	SteroidsIBA 04/2021
1	Opiate AlkaloidsIBA 04/2021
1	Lidocaine (Xylocaine)FDA LinkGeneric 04/2021
1	Morphine (MS Contin)FDA LinkGeneric 02/2020
1	Narcotics (Narcotic Analgesics)IBA 02/2020

Therapy/Procedure

30	Therapeutics 02/2024 - 07/2013
11	Microspheres (Microsphere) 01/2023 - 09/2015
8	Drug Therapy (Chemotherapy) 01/2023 - 02/2014
6	Segmental Mastectomy (Lumpectomy) 10/2023 - 03/2021
4	Radiotherapy 02/2024 - 01/2021
3	Hysterectomy 01/2023 - 10/2020
3	Uterine Artery Embolization 12/2022 - 02/2020
2	Vena Cava Filters (Inferior Vena Cava Filter) 12/2023 - 11/2022
2	Liver Transplantation 07/2023 - 01/2021
2	Radiofrequency Ablation 03/2022 - 04/2021
2	Length of Stay 01/2022 - 01/2020
2	Conservative Treatment 04/2021 - 11/2014
2	Aftercare (After-Treatment) 04/2021 - 06/2020
2	Analgesia 04/2021 - 02/2020
2	Gastrostomy 01/2021 - 11/2019
2	Nephrectomy 07/2018 - 01/2018
1	Transjugular Intrahepatic Portasystemic Shunt 12/2023
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2023
1	Continuity of Patient Care 10/2023
1	Cardiopulmonary Resuscitation (CPR) 01/2023
1	Laparotomy 06/2022
1	Replacement Arthroplasty 03/2022
1	Surgical Instruments (Clip) 01/2022
1	Knee Replacement Arthroplasty (Total Knee Replacement) 04/2021
1	Injections 04/2021
1	Splenectomy 01/2021
1	Uterine Myomectomy 10/2020
1	Endometrial Ablation Techniques 10/2020
1	Nerve Block (Nerve Blocks) 02/2020
1	Immunotherapy 02/2020
1	Central Venous Catheters 01/2020